baber/WOPTO huggingface dataset:
Patent EP-2808413-A1 (EP)
Inventor: KOSAKA NORIAKI
IPC: C23C2/28
Filed: 2013-01-21
Abstract: The present invention provides a high-strength hot-rolled steel sheet having both excellent strength and excellent workability (particularly, bending workability), and a method of producing the same. 
     The steel sheet of the present invention has a certain composition as well as microstructures such that an area ratio of ferrite phase is 95 % or more, an average grain size of the ferrite phase is 8 µm or less, and carbides in grains of the ferrite phase have an average particle size of less than 10 nm. The steel sheet of the present invention also has a tensile strength of 980 MPa or more.
Patent EP-2944133-A1 (EP)
Inventor: SEMAAN ELIANE
IPC: H04W52/36
Filed: 2013-07-15
Abstract: A UE and a method performed by the UE for power control of uplink transmissions, when the UE is connected in dual connectivity mode to at least a first network node and a second network node are provided. The method comprises determining (210) to perform a first uplink transmission to the first network node and a second uplink transmission to the second network node, the uplink transmissions to be performed simultaneously. The method also comprises determining (220) a respective first and second uplink transmission power for the first and the second uplink transmission; and transmitting (240) the first and the second uplink transmissions at the first and the second uplink transmission power respectively when the sum of the first and second uplink transmission power is below a maximum transmission power.
Patent EP-2874630-A1 (EP)
Inventor: GONZALES ANDREA J
IPC: A61P37/00
Filed: 2013-07-18
Abstract: La présente invention concerne une méthode de traitement de la dermatite allergique, de la dermatite atopique ou d'un ou de plusieurs symptômes de celles-ci, chez un mammifère nécessitant un tel traitement. Ladite méthode consiste à administrer au mammifère une première dose thérapeutiquement efficace d'un inhibiteur de la Janus kinase (JAK) deux fois par jour, pendant un nombre de jours suffisants pour faciliter ou supprimer un ou plusieurs signes cliniques chez ce mammifère, et à administrer ensuite une seconde dose thérapeutiquement efficace de l'inhibiteur de la JAK, à une fréquence réduite.
Patent EP-2816566-A1 (EP)
Inventor: IWAMURA YASUHIRO
IPC: G21B3/00
Filed: 2013-01-29
Abstract: A nuclide transmutation device and a nuclide transmutation method which enable nuclide transmutation to be performed in a relatively small-scale device compared with large-scale devices such as accelerators and nuclear reactors, wherein the amount of nuclide transmutation can be increased. The nuclide transmutation device comprises a structure (1), and a high deuterium concentration unit (2) and a low deuterium concentration unit (2) disposed on either side of the structure (1) so as to sandwich the structure (1) therebetween, wherein an electrolytic solution (16) containing heavy water is supplied to the high deuterium concentration unit (2), the electrolytic solution (16) is electrolyzed to generate deuterium, thereby producing a state of high deuterium concentration near the high deuterium concentration unit (2) side surface of the structure (1) and placing the low deuterium concentration unit (3) in a state of low deuterium concentration relative to the high deuterium concentration unit (2), causing the deuterium to deuterium to penetrate through the structure (1) from the high deuterium concentration unit (2) toward the low deuterium concentration unit (3), and subjecting a substance to undergo nuclide transmutation to nuclide transmutation in the structure (1) by reaction with the deuterium.
Patent EP-2900496-A1 (EP)
Inventor: GULIE CAMELIA
IPC: B60G21/05
Filed: 2013-07-05
Abstract: Motor vehicle rear axle assembly comprising a central crossbeam (1) perpendicular to the longitudinal direction of the vehicle and interposed between lateral arms (2) situated one on each side of the vehicle and connected by their front end (200) to the structure thereof and supporting at their rear end (201) vehicle rear wheel sub axle supports (3), characterized in that it comprises an aerodynamic fairing (5) covering, from underneath, the central crossbeam (5) and that part of the lateral arms (2) that extends between the ends of the central crossbeam (1) and the rear ends (201) of the lateral arms (2), the aerodynamic fairing (5) being a plastic component made in one piece with the overall shape of a U at least part of the central branch of the U of which is shaped to fit and close off a downwardly facing opening formed along the central crossbeam (1).
Patent EP-2866908-A1 (EP)
Inventor: VIGNATI FABRIZIO
IPC: A63C13/00
Filed: 2013-05-23
Abstract: The invention relates to the mountain winter sports equipment sector, and in particular to a snowshoe (1) comprising: - a plate (2) for resting on the snow and distributing a user's weight, having an upper face (2') and a lower face (2"); - means for fixing, at least partially, the user's foot to the upper face (2') of said plate (2); - a plurality of spikes (3), where said plate (2) comprises a mobile structure (4) adapted to make said plurality of spikes (3) alternately available below the lower face (2") of said plate (2), so as to define an uphill and a downhill configuration.
Patent EP-2812354-A1 (EP)
Title: Régulation de l'angiogenèse par emp2 dans les cellules cancéreuses par le biais de l'induction de vegf
Inventor: WADEHRA MADHURI
IPC: C07K16/00
Filed: 2013-02-06
Abstract: La présente invention concerne des procédés et des compositions pour la modulation de la néovascularisation. Les compositions de l'invention sont particulièrement utiles dans le traitement de cancers de l'utérus, notamment les cancers de l'endomètre.
Patent EP-2861572-A1 (EP)
Inventor: MUDDASANI PULLA REDDY
IPC: C07C15/02
Filed: 2013-06-19
Abstract: La présente invention porte sur un procédé perfectionné et industriel pour la préparation de dérivés d'acide 2-(7-méthylbenzo[d][1,3]dioxol-4-yl 6-substitué) acétique 2-substitué de formule I [Formule I], dans laquelle R 1  représente un groupe protecteur de O tel qu'un groupe méthoxyméthyle, éthoxyméthyle, trialkylsilyle, arylméthyle, tétrahydropyran-2-yl et allyle ; X représente un groupe hydroxyle, un atome d'halogène, un groupe mésylate, un groupe triflate, un groupe tosylate ou un groupe acétate ; Y représente l'atome d'oxygène, NH ou l'atome de soufre ; et R 2  représente un groupe alkyle en C 1 -C 6 . Du 2,4-dihydroxy-3-méthylbenzaldéhyde est sélectivement protégé au niveau de la position C-4 sous la forme d'un composé éther de formule XII, la fonction aldéhyde est oxydée pour obtenir le diol de formule XIII et le produit est condensé avec du glyoxalate d'éthyle dans des conditions de réaction de Casiraghi pour obtenir le composé de formule XV. Le composé de formule XV est converti en composé de formule I par de la chimie classique. Les composés de formule I sont des intermédiaires clés dans la synthèse d'ecteinascidines comme la trabectédine.
Patent EP-2821012-A1 (EP)
Inventor: BANJANIN ZORAN
IPC: A61B8/00
Filed: 2013-02-28
Abstract: According to one embodiment, the an ultrasound diagnosis apparatus acquires an ultrasound data by an ultrasound scanning of a patient via an ultrasound probe, generates an ultrasound image using the ultrasound data and displays the ultrasound image; and is provided with a detection unit, a command generation unit, and a control unit. The detection unit detects a non-touch input instruction from an operator. The command generation unit generates an input command in response to the non-touch input instruction. The control unit controls the ultrasound diagnosis apparatus in response to the input command.
Patent EP-2872313-A1 (EP)
Inventor: DEAU THIERRY
IPC: B29C49/78
Filed: 2013-07-09
Abstract: A control system (32) of an installation (1) for producing containers (2) from blanks (3) made from a thermoplastic material, said installation (1) comprising at least two units (4, 9) for processing the blanks (3) or the containers (2), each provided with at least one station (5, 10) for processing the blanks (3) or the containers (2), said control system (32) comprising a central control unit (33) of the installation (1), at least two control units (36, 46) slaved to the central control unit (33) and each associated respectively with a processing unit (9, 4), and at least two controllers (37, 47) each slaved to a control unit (36, 46) and each associated with at least one processing station (10, 5).
Patent EP-2824060-A1 (EP)
Inventor: KOYAMA KOJI
IPC: F16G11/12
Filed: 2013-02-21
Abstract: A hand operated pulling and lifting hoist includes: a change gear that engages with a switching pawl fitting provided for an operation lever to convert a manual force applied to the operation lever into a hoist driving force; a fixed support ring disposed for the rotatable mounting of the operation lever about a driving member that is set about the drive shaft to transmit the hoist driving force to the drive shaft; a pivotable support ring formed on the operation lever and rotatably fitted to an internal circumference of the fixed support ring; and a driving-member contact prevention part on the change gear to prevent contact between the pivotable support ring and the driving member.
Patent EP-2827126-A1 (EP)
Title: Microparticle detection system
Inventor: MOTOMURA MASAYUKI
IPC: G01R31/02
Filed: 2013-03-08
Abstract: An object is to provide a particulate detection system which detects the amount of particulates when the amount of particulates can be detected properly. A particulate detection system 1 for detecting the amount of particulates S in a gas under measurement EG includes a detection section 10 which is mounted to an exhaust pipe EP, a drive circuit 210, 240 for driving the detection section 10, and a drive control section 225 for controlling the drive circuit 210, 240. The detection section 10 includes a first potential member 31, 12, 13 maintained at a first potential PV1, a second potential member 14, 51, 53 maintained at a second potential PVE, PV3, and an insulating member 121, 77, 76 disposed between the first potential member 31, 12, 13 and the second potential member 14, 51, 53 so as to electrically insulate them from each other. The system 1 includes insulation test means 215, S3, 245, S5 for testing the degree of insulation between the first potential member 31, 12, 13 and the second potential member 14, 51, 53. The drive control section 225 includes drive permission/prohibition determination means S4, S6 for determining, on the basis of the degree of insulation tested by the insulation test means 215, S3, 245, S5, whether to permit the drive of the detection section 10 by the drive circuit 210, 240.
Patent EP-2911918-A1 (EP)
Title: Sicherheitsgurtanordnung für ein fahrzeug
Inventor: EFFENBERGER WITALI
IPC: B60R22/195
Filed: 2013-09-11
Abstract: Die Erfindung betrifft eine Sicherheitsgurtanordnung für ein Fahrzeug, mit einem Sicherheitsgurt, der einen Schultergurtabschnitt und einen Beckengurtabschnitt (6) aufweist, der an seinem in der Fahrzeugquerrichtung (y) äußeren Anlenkpunkt (A) einen Gurtumlenker (13) aufweist, über den der Beckengurtabschnitt (6) zu einer Gurtstraffer-Einrichtung (19) im Bereich eines Türschwellers (7) geführt ist. Erfindungsgemäß weist der Türschweller (7) ein Halteprofilteil (27) auf, das eine den Türeinstiegsbereich begrenzende Einstiegsleiste (4) trägt, wobei zwischen dem Halteprofilteil (27) und einer darunter liegenden Bodengruppe (41) des Fahrzeuges ein Bauraum (33) gebildet ist, in dem die Gurtstraffer-Einrichtung (19) angeordnet ist.
Patent EP-2900659-A1 (EP)
Inventor: JAESCHKE GEORG
IPC: C07D413/04
Filed: 2013-09-23
Abstract: The present invention relates to ethynyl derivatives of formula (I) wherein • R is phenyl, 3-fluorophenyl, 4-fluorophenyl or 2,5-di-fluorophenyl; • or to a pharmaceutically acceptable acid addition salt, in enantiomerically pure form with the absolute configuration as shown in formula (I). It has now surprisingly been found that the compounds of general formula I are allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5) whic are useful for he treatment of schizophrenia, cognitive disorders, fragile X sydrome or autism and which show advantageous biochemical-, physicochemical- and pharmacodynamic- properties compared to compounds of prior art.
Patent EP-3047225-A1 (EP)
Inventor: COOPER JIM
IPC: F28F19/00
Filed: 2013-09-19
Abstract: A stack of heating surface elements includes a first heating surface element (4) having first (10), second (12) and third (14) zones arranged sequentially along a primary gas flow direction (A). The first zone (10) includes a herringbone structure, the second zone (12) includes a flat structure, and the third zone (14) includes a plurality of corrugations extending in the primary gas flow direction (A). The corrugations have flat peak and trough regions. The stack also includes a second heating surface element (36), where the second heating surface element includes a plurality of corrugations extending in the primary gas flow direction (A).
Patent EP-2903769-A1 (EP)
Inventor: COAKLEY ROY C
IPC: B23D21/04
Filed: 2013-10-02
Abstract: A pipe machining apparatus (20) includes a frame (28), a tool carrier (32) coupled to and movable relative to the frame (28), and a tool support (48) coupled to and movable with the tool carrier (32) relative to the frame (28). The tool support 48) is adapted to support a tool (52) and move the tool (52) in a first direction toward a pipe at a first increment and move the tool (52) in a second direction away from the pipe at a second increment. The second increment is larger than the first increment.
Patent EP-2845356-A1 (EP)
Title: Appareil et procédé pour la gestion d'un faisceau de canaux de commande dans un système sans fil avec un grand nombre d'antennes
Inventor: LI YING
IPC: H04L27/26
Filed: 2013-04-30
Abstract: Selon l'invention, des stations de base (BS) sont configurées pour réaliser une transmission coordonnée vers au moins un équipement d'utilisateur (UE). La BS comprend une pluralité d'antennes configurée pour communiquer avec l'UE. La BS comprend également une circuiterie de traitement couplée à la pluralité d'antennes et configurée pour transmettre un canal de commande de liaison descendante physique (PDCCH) audit équipement d'utilisateur. L'UE comprend une pluralité d'antennes configurée pour communiquer avec la BS. L'UE comprend également une circuiterie de traitement couplée à la pluralité d'antennes et configurée pour recevoir le PDCCH de la BS. Le PDCCH est compris dans un ou plusieurs faisceaux de transmission (Tx). Un faisceau Tx est défini par un signal de référence spécifique à une cellule (CRS) transmis grâce au faisceau Tx. Un faisceau Tx est configuré pour porter un identifiant de faisceau, et le PDCCH est configuré pour comprendre des informations d'attribution de ressources pour l'équipement d'utilisateur.
Patent EP-2847701-A1 (EP)
Title: Système et procédé pour déterminer automatiquement l'efficacité relative de médicaments candidats anticancéreux
Inventor: PERREE MATHIEU
IPC: G06F19/00
Filed: 2013-05-02
Abstract: L'invention concerne un système informatique pour déterminer l'efficacité relative de médicaments anticancéreux. L'interface a des options pouvant être sélectionnées, comprenant une option pour gérer des paramètres de test de médicament, et permet une sélection par l'utilisateur de paramètres de test de médicament souhaités concernant une plaque de cupule virtuelle associée à une plaque de cupule physique d'un spectrophotomètre. Le système informatique amène le spectrophotomètre à démarrer un test de médicament, la plaque de cupule physique comprenant au moins une cupule de test contenant des cellules cancéreuses viables ; et au moins un médicament candidat dans une concentration prédéterminée ; et au moins une cupule témoin contenant les cellules cancéreuses viables seules. Le système enregistre la densité optique de la cupule à une longueur d'onde prédéterminée à intervalles de temps sélectionnés pendant une durée sélectionnée, et stocke les mesures de densité optique et de temps dans la base de données. Une valeur d'activité est calculée à partir des mesures de densité optique et de temps, et une corrélation est affichée entre la valeur d'activité et la capacité du médicament candidat à induire une apoptose dans les cellules cancéreuses.
Patent EP-2911990-A1 (EP)
Inventor: SMITH NICHOLAS JAMES
IPC: C03C23/00
Filed: 2013-10-22
Abstract: A thermo-electric method for texturing a glass surface including, for example, simultaneously heating a glass substrate to a temperature less than its glass transition temperature and applying a bias across the glass substrate using a template electrode. The applied bias at the processing temperature induces localized ion migration within the glass, which results in the formation in the glass surface of a negative topographical image of the pattern formed in the electrode.
Patent EP-2849049-A1 (EP)
Inventor: KANG PIL-GU
IPC: G06F3/12
Filed: 2013-04-24
Abstract: Disclosed are an apparatus and a method for controlling printing. The present invention controls so that outputted data with respect to an outputted product is printed by varying the number of pages which are printed on each unit sheet. According to the present invention, by controlling so that the outputted data is printed by varying the number of pages that are printed on each of the unit sheets, printing material consumed in printing the outputted data, such as paper sheets, ink, and toner, can be saved.
Patent EP-2914313-A1 (EP)
Title: Abpumpeinheit zum abpumpen von muttermilch
Inventor: SCHLIENGER André
IPC: A61M1/06
Filed: 2013-10-31
Abstract: Eine Abpumpeinheit zur Verwendung in einer Vorrichtung zum Abpumpen von menschlicher Muttermilch weist eine Brusthaube (3) zur Anlage an eine Mutterbrust und einen formstabilen oder annähernd formstabilen Milchsammelbehälter (1, 2) zur Aufnahme der abgepumpten Muttermilch auf. Die Brusthaube (3) weist eine erste Längsmittelachse (a) und der Milchsammelbehälter (1, 2) eine zweite Längsmittelachse (b) auf, wobei der Milchsammelbehälter (1, 2) lösbar an der Brusthaube (3) befestigbar ist und wobei die erste Längsmittelachse (a) im befestigten Zustand des Milchsammelbehälters (1, 2) in einem Winkel zur zweiten Längsmittelachse (b) angeordnet ist. Der Milchsammelbehälter (1, 2) ist im befestigten Zustand relativ zur Brusthaube (3) bewegbar, wodurch der Winkel zwischen der ersten und zweiten Längsmittelachse (a, b) veränderbar ist. Die erfindungsgemässe Abpumpeinheit lässt sich kompakt und platzsparend ausbilden und eignet sich insbesondere in einer„hands-free" Anordnung.
Patent EP-2840627-A1 (EP)
Inventor: LENT STEVEN
IPC: H01M10/0525
Filed: 2013-05-16
Abstract: A battery module mounting assembly is provided. The assembly includes a base plate, and a first retention clamp having a first plate of uniform thickness. The first plate has a central rib, first and second base portions, and first and second clamping portions. The first and second base portions extend from first and second sides, respectively, of the central rib, and are fixedly attached to the base plate. The first clamping portion extends outwardly from the first base portion. The first clamping portion holds a first portion of a first battery module housing. The second clamping portion extends outwardly from the second base portion. The second clamping portion holds a second portion of a second battery module housing.
Patent EP-2855504-A1 (EP)
Inventor: GAGNON PETER STANLEY
IPC: C07K16/32
Filed: 2013-01-21
Abstract: A method of purifying a sample containing a desired protein includes the steps of (i) providing a packed chromatographic column having positively charged porous particles, (ii) equilibrating the column to the conditions to which the desired protein in the sample is to elute, (iii) contacting the sample with the packed chromatographic column such that the sample volume applied to the packed chromatographic column is less than or equal to the interparticle space of the positively charged porous particles within the packed chromatographic column, (iv) eluting the desired protein from the packed chromatographic column, where the desired protein is in a purer state and in the conditions to which the packed chromatographic column was equilibrated; where the desired protein is an antibody, an antibody fragment, an antibody derivative, or an antibody fusion protein. (No suitable Figure)
Patent EP-2858470-A1 (EP)
Title: Magnetic field shielding sheet for digitizer, method for manufacturing same, and portable terminal device using same
Inventor: JANG KIL JAE
IPC: B32B27/32
Filed: 2013-06-04
Abstract: Provided are a magnetic field shielding sheet for a digitizer, which shields an effect of a magnetic field generated from various components of a main body of the portable terminal device and at the same time improves the sensitivity of a digitizer function when the digitizer function is implemented in the portable terminal device, while minimizing an influence upon a geomagnetic sensor, a method of manufacturing the magnetic field shielding sheet, and a portable terminal device using the magnetic field shielding sheet. The magnetic field shielding sheet includes: at least one layer thin magnetic sheet made of a Fe-based amorphous alloy and flake-treated so as to be separated into a plurality of fine pieces; a protective film that is adhered on one surface of the thin magnetic sheet via a first adhesive layer provided on one side of the protective film; and a double-sided tape that is adhered on the other surface of the thin magnetic sheet via a second adhesive layer provided on one side of the double-sided adhesive tape, wherein the thin magnetic sheet is obtained by heat treating an amorphous ribbon sheet made of the Fe-based amorphous alloy at a temperature of 300°C to 480°C.
Patent EP-2869632-A1 (EP)
Inventor: HUANG QUFANG
IPC: H04W12/041
Filed: 2013-06-24
Abstract: Embodiments of the present invention disclose a primary secondary cell change method and a base station, which relate to the communications field, and can adjust a primary secondary cell in a process of carrier aggregation, thereby improving the communication efficiency. The primary secondary cell change method in the embodiments of the present invention includes: determining, by a primary base station, to change a first primary secondary cell served by a secondary base station, and selecting a second primary secondary cell from cells served by the secondary base station; sending, by the primary base station, a first message to the secondary base station, which is used to request the secondary base station to change the primary secondary cell, where the first message includes an identity of the second primary secondary cell; and sending, by the primary base station, a second message to a user equipment UE, which is used to request the UE to use the second primary secondary cell.
Patent EP-2868629-A1 (EP)
Inventor: ZHENG JINYU
IPC: C01B39/24
Filed: 2013-06-27
Abstract: The present invention provides a rare earth-containing Y zeolite and a preparation process thereof, said rare earth-containing Y zeolite has a rare earth content as rare earth oxide of 10-25wt%, a unit cell size of 2.440-2.472nm, a crystallinity of 35-65%, a Si/Al atom ratio in the skeleton of 2.5-5.0; and a product of the ratio of the strength I 1  of the peak at 2θ=11.8±0.1° to the strength I 2  of the peak at 2θ=12.3±0.1° in the X-ray diffraction spectrogram of the zeolite and the weight percent of rare earth as rare earth oxide in the zeolite of higher than 48.